 | • レポートコード：GIR-105X19873 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、皮下注射免疫グロブリンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。皮下注射免疫グロブリンの種類別市場規模（10％純度、20％純度）、用途別市場規模（原発性免疫不全症、二次性免疫不全症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・皮下注射免疫グロブリンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Shire (Baxalta)、Grifols、CSL ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：10％純度、20％純度 ・用途別分析2016年-2026年：原発性免疫不全症、二次性免疫不全症、その他 ・皮下注射免疫グロブリンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・皮下注射免疫グロブリンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・皮下注射免疫グロブリンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・皮下注射免疫グロブリンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・皮下注射免疫グロブリンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Subcutaneous Injection Immunoglobulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Subcutaneous Injection Immunoglobulin size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Subcutaneous Injection Immunoglobulin market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Subcutaneous Injection Immunoglobulin market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
10% Purity
20% Purity
Market segment by Application can be divided into
Primary Immunodeficiency
Secondary Immunodeficiency
Others
The key market players for global Subcutaneous Injection Immunoglobulin market are listed below:
Shire (Baxalta)
Grifols
CSL
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Subcutaneous Injection Immunoglobulin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Subcutaneous Injection Immunoglobulin Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 10% Purity
1.2.3 20% Purity
1.3 Market Analysis by Application
1.3.1 Overview: Global Subcutaneous Injection Immunoglobulin Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Primary Immunodeficiency
1.3.3 Secondary Immunodeficiency
1.3.4 Others
1.4 Global Subcutaneous Injection Immunoglobulin Market Size & Forecast
1.4.1 Global Subcutaneous Injection Immunoglobulin Sales in Value (2016-2026))
1.4.2 Global Subcutaneous Injection Immunoglobulin Sales in Volume (2016-2026)
1.4.3 Global Subcutaneous Injection Immunoglobulin Price by Type (2016-2026) & (USD/Unit)
1.5 Global Subcutaneous Injection Immunoglobulin Production Capacity Analysis
1.5.1 Global Subcutaneous Injection Immunoglobulin Total Production Capacity (2016-2026)
1.5.2 Global Subcutaneous Injection Immunoglobulin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Subcutaneous Injection Immunoglobulin Market Drivers
1.6.2 Subcutaneous Injection Immunoglobulin Market Restraints
1.6.3 Subcutaneous Injection Immunoglobulin Trends Analysis
2 Manufacturers Profiles
2.1 Shire (Baxalta)
2.1.1 Shire (Baxalta) Details
2.1.2 Shire (Baxalta) Major Business
2.1.3 Shire (Baxalta) Subcutaneous Injection Immunoglobulin Product and Services
2.1.4 Shire (Baxalta) Subcutaneous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Grifols
2.2.1 Grifols Details
2.2.2 Grifols Major Business
2.2.3 Grifols Subcutaneous Injection Immunoglobulin Product and Services
2.2.4 Grifols Subcutaneous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 CSL
2.3.1 CSL Details
2.3.2 CSL Major Business
2.3.3 CSL Subcutaneous Injection Immunoglobulin Product and Services
2.3.4 CSL Subcutaneous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Subcutaneous Injection Immunoglobulin Sales by Manufacturer
3.1 Global Subcutaneous Injection Immunoglobulin Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Subcutaneous Injection Immunoglobulin Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Subcutaneous Injection Immunoglobulin
3.4 Market Concentration Rate
3.4.1 Top 3 Subcutaneous Injection Immunoglobulin Manufacturer Market Share
3.4.2 Top 6 Subcutaneous Injection Immunoglobulin Manufacturer Market Share
3.5 Global Subcutaneous Injection Immunoglobulin Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Subcutaneous Injection Immunoglobulin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Subcutaneous Injection Immunoglobulin Market Size by Region
4.1.1 Global Subcutaneous Injection Immunoglobulin Sales in Volume by Region (2016-2026)
4.1.2 Global Subcutaneous Injection Immunoglobulin Revenue by Region (2016-2026)
4.2 North America Subcutaneous Injection Immunoglobulin Revenue (2016-2026)
4.3 Europe Subcutaneous Injection Immunoglobulin Revenue (2016-2026)
4.4 Asia-Pacific Subcutaneous Injection Immunoglobulin Revenue (2016-2026)
4.5 South America Subcutaneous Injection Immunoglobulin Revenue (2016-2026)
4.6 Middle East and Africa Subcutaneous Injection Immunoglobulin Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Subcutaneous Injection Immunoglobulin Sales in Volume by Type (2016-2026)
5.2 Global Subcutaneous Injection Immunoglobulin Revenue by Type (2016-2026)
5.3 Global Subcutaneous Injection Immunoglobulin Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Subcutaneous Injection Immunoglobulin Sales in Volume by Application (2016-2026)
6.2 Global Subcutaneous Injection Immunoglobulin Revenue by Application (2016-2026)
6.3 Global Subcutaneous Injection Immunoglobulin Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Subcutaneous Injection Immunoglobulin Sales by Type (2016-2026)
7.2 North America Subcutaneous Injection Immunoglobulin Sales by Application (2016-2026)
7.3 North America Subcutaneous Injection Immunoglobulin Market Size by Country
7.3.1 North America Subcutaneous Injection Immunoglobulin Sales in Volume by Country (2016-2026)
7.3.2 North America Subcutaneous Injection Immunoglobulin Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Subcutaneous Injection Immunoglobulin Sales by Type (2016-2026)
8.2 Europe Subcutaneous Injection Immunoglobulin Sales by Application (2016-2026)
8.3 Europe Subcutaneous Injection Immunoglobulin Market Size by Country
8.3.1 Europe Subcutaneous Injection Immunoglobulin Sales in Volume by Country (2016-2026)
8.3.2 Europe Subcutaneous Injection Immunoglobulin Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Subcutaneous Injection Immunoglobulin Sales by Type (2016-2026)
9.2 Asia-Pacific Subcutaneous Injection Immunoglobulin Sales by Application (2016-2026)
9.3 Asia-Pacific Subcutaneous Injection Immunoglobulin Market Size by Region
9.3.1 Asia-Pacific Subcutaneous Injection Immunoglobulin Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Subcutaneous Injection Immunoglobulin Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Subcutaneous Injection Immunoglobulin Sales by Type (2016-2026)
10.2 South America Subcutaneous Injection Immunoglobulin Sales by Application (2016-2026)
10.3 South America Subcutaneous Injection Immunoglobulin Market Size by Country
10.3.1 South America Subcutaneous Injection Immunoglobulin Sales in Volume by Country (2016-2026)
10.3.2 South America Subcutaneous Injection Immunoglobulin Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Subcutaneous Injection Immunoglobulin Sales by Type (2016-2026)
11.2 Middle East & Africa Subcutaneous Injection Immunoglobulin Sales by Application (2016-2026)
11.3 Middle East & Africa Subcutaneous Injection Immunoglobulin Market Size by Country
11.3.1 Middle East & Africa Subcutaneous Injection Immunoglobulin Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Subcutaneous Injection Immunoglobulin Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Subcutaneous Injection Immunoglobulin Typical Distributors
12.3 Subcutaneous Injection Immunoglobulin Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Subcutaneous Injection Immunoglobulin Revenue by Type, (USD Million), 2021-2026
Table 2. Global Subcutaneous Injection Immunoglobulin Revenue by Application, (USD Million), 2021-2026
Table 3. Shire (Baxalta) Basic Information, Manufacturing Base and Competitors
Table 4. Shire (Baxalta) Major Business
Table 5. Shire (Baxalta) Subcutaneous Injection Immunoglobulin Product and Services
Table 6. Shire (Baxalta) Subcutaneous Injection Immunoglobulin Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Grifols Basic Information, Manufacturing Base and Competitors
Table 8. Grifols Major Business
Table 9. Grifols Subcutaneous Injection Immunoglobulin Product and Services
Table 10. Grifols Subcutaneous Injection Immunoglobulin Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. CSL Basic Information, Manufacturing Base and Competitors
Table 12. CSL Major Business
Table 13. CSL Subcutaneous Injection Immunoglobulin Product and Services
Table 14. CSL Subcutaneous Injection Immunoglobulin Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Global Subcutaneous Injection Immunoglobulin Sales by Manufacturer (2019-2021e) & (K Units)
Table 16. Global Subcutaneous Injection Immunoglobulin Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 17. Market Position of Manufacturers in Subcutaneous Injection Immunoglobulin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 18. Global Subcutaneous Injection Immunoglobulin Production Capacity by Company, (K Units): 2020 VS 2021
Table 19. Head Office and Subcutaneous Injection Immunoglobulin Production Site of Key Manufacturer
Table 20. Global Subcutaneous Injection Immunoglobulin Sales by Region (2016-2021e) & (K Units)
Table 21. Global Subcutaneous Injection Immunoglobulin Sales by Region (2021-2026) & (K Units)
Table 22. Global Subcutaneous Injection Immunoglobulin Revenue by Region (2016-2021e) & (USD Million)
Table 23. Global Subcutaneous Injection Immunoglobulin Revenue by Region (2021-2026) & (USD Million)
Table 24. Global Subcutaneous Injection Immunoglobulin Sales by Type (2016-2021e) & (K Units)
Table 25. Global Subcutaneous Injection Immunoglobulin Sales by Type (2021-2026) & (K Units)
Table 26. Global Subcutaneous Injection Immunoglobulin Revenue by Type (2016-2021e) & (USD Million)
Table 27. Global Subcutaneous Injection Immunoglobulin Revenue by Type (2021-2026) & (USD Million)
Table 28. Global Subcutaneous Injection Immunoglobulin Price by Type (2016-2021e) & (USD/Unit)
Table 29. Global Subcutaneous Injection Immunoglobulin Price by Type (2021-2026) & (USD/Unit)
Table 30. Global Subcutaneous Injection Immunoglobulin Sales by Application (2016-2021e) & (K Units)
Table 31. Global Subcutaneous Injection Immunoglobulin Sales by Application (2021-2026) & (K Units)
Table 32. Global Subcutaneous Injection Immunoglobulin Revenue by Application (2016-2021e) & (USD Million)
Table 33. Global Subcutaneous Injection Immunoglobulin Revenue by Application (2021-2026) & (USD Million)
Table 34. Global Subcutaneous Injection Immunoglobulin Price by Application (2016-2021e) & (USD/Unit)
Table 35. Global Subcutaneous Injection Immunoglobulin Price by Application (2021-2026) & (USD/Unit)
Table 36. North America Subcutaneous Injection Immunoglobulin Sales by Country (2016-2021e) & (K Units)
Table 37. North America Subcutaneous Injection Immunoglobulin Sales by Country (2021-2026) & (K Units)
Table 38. North America Subcutaneous Injection Immunoglobulin Revenue by Country (2016-2021e) & (USD Million)
Table 39. North America Subcutaneous Injection Immunoglobulin Revenue by Country (2021-2026) & (USD Million)
Table 40. North America Subcutaneous Injection Immunoglobulin Sales by Type (2016-2021e) & (K Units)
Table 41. North America Subcutaneous Injection Immunoglobulin Sales by Type (2021-2026) & (K Units)
Table 42. North America Subcutaneous Injection Immunoglobulin Sales by Application (2016-2021e) & (K Units)
Table 43. North America Subcutaneous Injection Immunoglobulin Sales by Application (2021-2026) & (K Units)
Table 44. Europe Subcutaneous Injection Immunoglobulin Sales by Country (2016-2021e) & (K Units)
Table 45. Europe Subcutaneous Injection Immunoglobulin Sales by Country (2021-2026) & (K Units)
Table 46. Europe Subcutaneous Injection Immunoglobulin Revenue by Country (2016-2021e) & (USD Million)
Table 47. Europe Subcutaneous Injection Immunoglobulin Revenue by Country (2021-2026) & (USD Million)
Table 48. Europe Subcutaneous Injection Immunoglobulin Sales by Type (2016-2021e) & (K Units)
Table 49. Europe Subcutaneous Injection Immunoglobulin Sales by Type (2021-2026) & (K Units)
Table 50. Europe Subcutaneous Injection Immunoglobulin Sales by Application (2016-2021e) & (K Units)
Table 51. Europe Subcutaneous Injection Immunoglobulin Sales by Application (2021-2026) & (K Units)
Table 52. Asia-Pacific Subcutaneous Injection Immunoglobulin Sales by Region (2016-2021e) & (K Units)
Table 53. Asia-Pacific Subcutaneous Injection Immunoglobulin Sales by Region (2021-2026) & (K Units)
Table 54. Asia-Pacific Subcutaneous Injection Immunoglobulin Revenue by Region (2016-2021e) & (USD Million)
Table 55. Asia-Pacific Subcutaneous Injection Immunoglobulin Revenue by Region (2021-2026) & (USD Million)
Table 56. Asia-Pacific Subcutaneous Injection Immunoglobulin Sales by Type (2016-2021e) & (K Units)
Table 57. Asia-Pacific Subcutaneous Injection Immunoglobulin Sales by Type (2021-2026) & (K Units)
Table 58. Asia-Pacific Subcutaneous Injection Immunoglobulin Sales by Application (2016-2021e) & (K Units)
Table 59. Asia-Pacific Subcutaneous Injection Immunoglobulin Sales by Application (2021-2026) & (K Units)
Table 60. South America Subcutaneous Injection Immunoglobulin Sales by Country (2016-2021e) & (K Units)
Table 61. South America Subcutaneous Injection Immunoglobulin Sales by Country (2021-2026) & (K Units)
Table 62. South America Subcutaneous Injection Immunoglobulin Revenue by Country (2016-2021e) & (USD Million)
Table 63. South America Subcutaneous Injection Immunoglobulin Revenue by Country (2021-2026) & (USD Million)
Table 64. South America Subcutaneous Injection Immunoglobulin Sales by Type (2016-2021e) & (K Units)
Table 65. South America Subcutaneous Injection Immunoglobulin Sales by Type (2021-2026) & (K Units)
Table 66. South America Subcutaneous Injection Immunoglobulin Sales by Application (2016-2021e) & (K Units)
Table 67. South America Subcutaneous Injection Immunoglobulin Sales by Application (2021-2026) & (K Units)
Table 68. Middle East & Africa Subcutaneous Injection Immunoglobulin Sales by Country (2016-2021e) & (K Units)
Table 69. Middle East & Africa Subcutaneous Injection Immunoglobulin Sales by Country (2021-2026) & (K Units)
Table 70. Middle East & Africa Subcutaneous Injection Immunoglobulin Revenue by Country (2016-2021e) & (USD Million)
Table 71. Middle East & Africa Subcutaneous Injection Immunoglobulin Revenue by Country (2021-2026) & (USD Million)
Table 72. Middle East & Africa Subcutaneous Injection Immunoglobulin Sales by Type (2016-2021e) & (K Units)
Table 73. Middle East & Africa Subcutaneous Injection Immunoglobulin Sales by Type (2021-2026) & (K Units)
Table 74. Middle East & Africa Subcutaneous Injection Immunoglobulin Sales by Application (2016-2021e) & (K Units)
Table 75. Middle East & Africa Subcutaneous Injection Immunoglobulin Sales by Application (2021-2026) & (K Units)
Table 76. Direct Channel Pros & Cons
Table 77. Indirect Channel Pros & Cons
Table 78. Subcutaneous Injection Immunoglobulin Typical Distributors
Table 79. Subcutaneous Injection Immunoglobulin Typical Customers
List of Figures
Figure 1. Subcutaneous Injection Immunoglobulin Picture
Figure 2. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Type in 2020
Figure 3. 10% Purity
Figure 4. 20% Purity
Figure 5. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Application in 2020
Figure 6. Primary Immunodeficiency
Figure 7. Secondary Immunodeficiency
Figure 8. Others
Figure 9. Global Subcutaneous Injection Immunoglobulin Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Subcutaneous Injection Immunoglobulin Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Subcutaneous Injection Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Subcutaneous Injection Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Subcutaneous Injection Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Subcutaneous Injection Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Subcutaneous Injection Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Subcutaneous Injection Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Subcutaneous Injection Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Subcutaneous Injection Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Subcutaneous Injection Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Subcutaneous Injection Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Subcutaneous Injection Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Subcutaneous Injection Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Subcutaneous Injection Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Subcutaneous Injection Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Subcutaneous Injection Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Subcutaneous Injection Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Subcutaneous Injection Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Subcutaneous Injection Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Subcutaneous Injection Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Subcutaneous Injection Immunoglobulin Sales (2016-2026) & (K Units)
Figure 31. Global Subcutaneous Injection Immunoglobulin Production Capacity (2016-2026) & (K Units)
Figure 32. Global Subcutaneous Injection Immunoglobulin Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Subcutaneous Injection Immunoglobulin Market Drivers
Figure 34. Subcutaneous Injection Immunoglobulin Market Restraints
Figure 35. Subcutaneous Injection Immunoglobulin Market Trends
Figure 36. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Manufacturer in 2020
Figure 37. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Manufacturer in 2020
Figure 38. Subcutaneous Injection Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Subcutaneous Injection Immunoglobulin Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Subcutaneous Injection Immunoglobulin Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Region (2016-2026)
Figure 42. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Region (2016-2026)
Figure 43. North America Subcutaneous Injection Immunoglobulin Revenue (2016-2026) & (USD Million)
Figure 44. Europe Subcutaneous Injection Immunoglobulin Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Subcutaneous Injection Immunoglobulin Revenue (2016-2026) & (USD Million)
Figure 46. South America Subcutaneous Injection Immunoglobulin Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Subcutaneous Injection Immunoglobulin Revenue (2016-2026) & (USD Million)
Figure 48. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2016-2026)
Figure 49. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Type (2016-2026)
Figure 50. Global Subcutaneous Injection Immunoglobulin Price by Type (2016-2026) & (USD/Unit)
Figure 51. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2016-2026)
Figure 52. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Application (2016-2026)
Figure 53. Global Subcutaneous Injection Immunoglobulin Price by Application (2016-2026) & (USD/Unit)
Figure 54. North America Subcutaneous Injection Immunoglobulin Sales Market Share by Country (2016-2026)
Figure 55. North America Subcutaneous Injection Immunoglobulin Revenue Market Share by Country (2016-2026)
Figure 56. North America Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2016-2026)
Figure 57. North America Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2016-2026)
Figure 58. Europe Subcutaneous Injection Immunoglobulin Sales Market Share by Country (2016-2026)
Figure 59. Europe Subcutaneous Injection Immunoglobulin Revenue Market Share by Country (2016-2026)
Figure 60. Europe Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2016-2026)
Figure 61. Europe Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Subcutaneous Injection Immunoglobulin Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Subcutaneous Injection Immunoglobulin Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Subcutaneous Injection Immunoglobulin Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2016-2026)
Figure 66. South America Subcutaneous Injection Immunoglobulin Sales Market Share by Country (2016-2026)
Figure 67. South America Subcutaneous Injection Immunoglobulin Revenue Market Share by Country (2016-2026)
Figure 68. South America Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2016-2026)
Figure 69. South America Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Subcutaneous Injection Immunoglobulin Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Subcutaneous Injection Immunoglobulin Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
免疫グロブリン製剤の世界市場2018-2025 This study focuses on the production side and consumption side of Immune Globulin Subcutaneous, presents the global Immune Globulin Subcutaneous market size by manufacturers, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.In terms of production side, th…- 世界の皮下植込み型除細動器市場 2021：企業別、地域別、種類・用途別 The Subcutaneous Implantable Defibrillators market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 世界の皮下ドラッグデリバリーデバイス市場 2021：企業別、地域別、種類・用途別 The Subcutaneous Drug Delivery Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 免疫グロブリン製品の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Immunoglobulin’s also called as antibodies are large Y-shaped protein produced by B-cell. These are the glycoprotein molecule produced by plasma cells in response to entry of foreign entity such as bacteria and viruses in the body. Production of antibodies is an important function of immune system.…
- 世界の注射用オマリズマブ市場 2021：企業別、地域別、種類・用途別 The Omalizumab for Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…